Spots Global Cancer Trial Database for fallopian tube carcinoma

Every month we try and update this database with for fallopian tube carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer	NCT01116648	Fallopian Tube ... Ovarian Endomet... Ovarian High Gr... Ovarian Serous ... Ovarian Serous ... Primary Periton... Triple-Negative...	Biopsy Biospecimen Col... Cediranib Malea... Computed Tomogr... Echocardiograph... Magnetic Resona... Multigated Acqu... Olaparib	18 Years -	National Cancer Institute (NCI)
A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer	NCT02344095	Epithelial Ovar... Fallopian Tube ... Primary Periton...	weekly paclitax... weekly cisplati... oncothermia	-	Seoul National University Hospital
ICON8: Weekly Chemotherapy in Ovarian Cancer	NCT01654146	Ovarian Cancer	Carboplatin Carboplatin Paclitaxel Paclitaxel	18 Years -	Medical Research Council
A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors	NCT03517488	Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce...	XmAb20717	18 Years -	Xencor, Inc.
A Trial of Intravenous Denileukin Diftitox in Stage III or IV Ovarian Cancer	NCT00880360	Epithelial Ovar... Extraovarian Pe... Fallopian Tube ...	Ontak	18 Years -	The University of Texas Health Science Center at San Antonio
EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	NCT01118052	Fallopian Tube ... Primary Periton... Recurrent Ovari...	Laboratory Biom... PEG-PEI-cholest...	18 Years -	GOG Foundation
Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	NCT00989651	Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Ovarian Brenner... Ovarian Carcino... Ovarian Carcino... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Seromuc... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Primary Periton... Primary Periton... Stage IIA Fallo... Stage IIA Ovari... Stage IIB Fallo... Stage IIB Ovari... Stage IIC Fallo... Stage IIC Ovari... Stage IIIA Fall... Stage IIIA Ovar... Stage IIIA Prim... Stage IIIB Fall... Stage IIIB Ovar... Stage IIIB Prim... Stage IIIC Fall... Stage IIIC Ovar... Stage IIIC Prim... Stage IV Fallop... Stage IV Ovaria... Stage IV Primar...	Bevacizumab Carboplatin Cisplatin Laboratory Biom... Paclitaxel Veliparib	18 Years -	National Cancer Institute (NCI)
Heated Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Peritoneal Cancer	NCT02199171	FIGO Stage IIC-... Fallopian Tube ... Peritoneal Carc...	carboplatin	18 Years -	University of California, Irvine
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies	NCT02419495	Advanced Malign... Clinical Stage ... Clinical Stage ... Fallopian Tube ... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Rena... Ovarian Carcino... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Primary Periton... Stage III Lung ... Stage III Renal... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IV Renal ... Stage IVA Lung ... Stage IVB Lung ... Triple-Negative... Unresectable Lu... Unresectable Me... Unresectable Re...	Capecitabine Carboplatin Cyclophosphamid... Doxorubicin Eribulin Fluorouracil Ipilimumab Irinotecan Hydr... Leucovorin Calc... Nivolumab Olaparib Oxaliplatin Paclitaxel Pembrolizumab Pemetrexed Selinexor Topotecan	18 Years -	M.D. Anderson Cancer Center
Trial of Chemotherapy in Ovarian, Fallopian Tube and Peritoneal Carcinoma	NCT01519869	Primary Periton... Ovarian Carcino... Fallopian Tube ...	neoadjuvant che...	18 Years -	University of Kentucky
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression	NCT06420973	Ovarian Carcino... Fallopian Tube ... Primary Periton...	RC48+carboplati...	18 Years - 75 Years	Peking University Cancer Hospital & Institute
Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer	NCT02788708	Fallopian Tube ... Recurrent Ovari... Primary Periton... Recurrent Endom...	Lenvatinib Mesy... Paclitaxel Pharmacological...	18 Years -	Ohio State University Comprehensive Cancer Center
Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer	NCT02530606	Fallopian Tube ... Ovarian Carcino...	Photoacoustic I...	18 Years - 80 Years	Stanford University
Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer	NCT02345265	Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Ovarian Carcino... Ovarian High Gr... Ovarian High Gr... Primary Periton... Primary Periton... Primary Periton...	Biopsy Biospecimen Col... Cediranib Malea... Computed Tomogr... Echocardiograph... Magnetic Resona... Multigated Acqu... Olaparib Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer	NCT02788708	Fallopian Tube ... Recurrent Ovari... Primary Periton... Recurrent Endom...	Lenvatinib Mesy... Paclitaxel Pharmacological...	18 Years -	Ohio State University Comprehensive Cancer Center
Hyperthermic Intraoperative Intraperitoneal Chemotherapy of Recurrent Ovarian Cancer - A Feasibility Study	NCT00968799	Epithelial Ovar... Fallopian Tube ...	Hyperthermic in... Cytoreduction Cisplatin	18 Years - 70 Years	Cantonal Hospital of St. Gallen
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer	NCT00352300	Fallopian Tube ... Infectious Diso... Neutropenia Ovarian Carcino... Primary Periton... Stage III Ovari... Stage IV Ovaria...	Adjuvant Therap... Carboplatin Paclitaxel Pegfilgrastim	18 Years -	GOG Foundation
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199	NCT01445275	Fallopian Tube ... Hereditary Brea... Ovarian Carcino... Primary Periton...	Evaluation of C... Medical Chart R... Study of Socioe...	30 Years -	GOG Foundation
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	NCT01295489	Fallopian Tube ... Ovarian Carcino... Primary Periton...	Laboratory Biom...	18 Years -	GOG Foundation
Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer	NCT03297489	Fallopian Tube ... Primary Periton... Stage I Ovarian... Stage IA Ovaria... Stage IB Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage IIA Ovari... Stage IIB Ovari... Stage IIC Ovari... Stage III Ovari... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria...	Diagnostic Micr... Fluorescein Sod... Laboratory Biom...	18 Years -	Roswell Park Cancer Institute
ITIL-306 in Advanced Solid Tumors	NCT05397093	Epithelial Ovar... Non-small Cell ... Renal Cell Carc...	ITIL-306	18 Years -	Instil Bio
Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma	NCT01381861	Recurrent Ovari... Fallopian Tube ... Primary Periton...	Carotuximab (TR...	18 Years -	Tracon Pharmaceuticals Inc.
Cost of Cancer Risk Management in Women at Elevated Genetic Risk for Ovarian Cancer Who Participated on GOG-0199	NCT01445275	Fallopian Tube ... Hereditary Brea... Ovarian Carcino... Primary Periton...	Evaluation of C... Medical Chart R... Study of Socioe...	30 Years -	GOG Foundation
Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy	NCT00377429	Ovarian Cancer	catumaxomab	18 Years -	Neovii Biotech
First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer	NCT01097746	Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... FIGO Stage III ... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIB... FIGO Stage IIIC... FIGO Stage IVA ... FIGO Stage IVB ... Malignant Ovari... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Seromuc... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Primary Periton... Primary Periton...	Bevacizumab Carboplatin Paclitaxel	18 Years -	M.D. Anderson Cancer Center
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer	NCT01116648	Fallopian Tube ... Ovarian Endomet... Ovarian High Gr... Ovarian Serous ... Ovarian Serous ... Primary Periton... Triple-Negative...	Biopsy Biospecimen Col... Cediranib Malea... Computed Tomogr... Echocardiograph... Magnetic Resona... Multigated Acqu... Olaparib	18 Years -	National Cancer Institute (NCI)
Standardized Extract of Cultured Lentinula Edodes Mycelia (AHCC®) in Ovarian Cancer Patients on Adjuvant Chemotherapy	NCT05763199	Ovarian Epithel... Fallopian Tube ... Peritoneal Carc...	AHCC Chemotherapy Placebo	18 Years -	University of California, Davis
A Trial of Weekly Paclitaxel With Oncothermia and Weekly cisPlatin With Oncothermia in Patients With Recurrent or Persistent Ovarian Cancer	NCT02344095	Epithelial Ovar... Fallopian Tube ... Primary Periton...	weekly paclitax... weekly cisplati... oncothermia	-	Seoul National University Hospital
Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer	NCT00060359	Fallopian Tube ... Malignant Ovari... Ovarian Brenner... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Primary Periton... Stage III Ovari... Stage IV Ovaria... Undifferentiate...	Carboplatin Paclitaxel Poli... Pharmacological...	18 Years -	GOG Foundation
Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer	NCT01139957	Breast Carcinom... Fallopian Tube ... Ovarian Neoplas... Primary Periton...	Evaluation of C... Quality-of-Life... Questionnaire A... Study of High R...	30 Years -	GOG Foundation
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF	NCT03604315	Breast Carcinom... Fallopian Tube ... Ovarian Carcino... Primary Periton... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Solid Neoplasm	Computed Tomogr... Computed Tomogr... Fludeoxyglucose... Fluorine F 18 F... Positron Emissi... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors	NCT00301756	Fallopian Tube ... Primary Periton... Recurrent Borde... Recurrent Ovari... Stage III Borde... Stage III Ovari... Stage IV Border... Stage IV Ovaria...	Belinostat Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery	NCT02315469	Endometrial Ser... Fallopian Tube ... Malignant Femal... Ovarian Carcino... Primary Periton... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Comprehensive G... Questionnaire A...	70 Years -	NRG Oncology
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery	NCT02315469	Endometrial Ser... Fallopian Tube ... Malignant Femal... Ovarian Carcino... Primary Periton... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Comprehensive G... Questionnaire A...	70 Years -	NRG Oncology
First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer	NCT01097746	Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... FIGO Stage III ... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIB... FIGO Stage IIIC... FIGO Stage IVA ... FIGO Stage IVB ... Malignant Ovari... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Seromuc... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Primary Periton... Primary Periton...	Bevacizumab Carboplatin Paclitaxel	18 Years -	M.D. Anderson Cancer Center
RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression	NCT06420973	Ovarian Carcino... Fallopian Tube ... Primary Periton...	RC48+carboplati...	18 Years - 75 Years	Peking University Cancer Hospital & Institute
Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer	NCT01202890	Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Primary Periton...	Lenalidomide, L... Revlimid, Doxil...	-	New Mexico Cancer Care Alliance
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	NCT00958698	Fallopian Tube ... Primary Periton... Psychological I... Recurrent Ovari...	Communication I... Educational Int... Internet-Based ... Psychosocial As... Quality-of-Life... Questionnaire A...	18 Years -	GOG Foundation
Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF	NCT03604315	Breast Carcinom... Fallopian Tube ... Ovarian Carcino... Primary Periton... Recurrent Fallo... Recurrent Ovari... Recurrent Prima... Solid Neoplasm	Computed Tomogr... Computed Tomogr... Fludeoxyglucose... Fluorine F 18 F... Positron Emissi... Positron Emissi...	18 Years -	M.D. Anderson Cancer Center
Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?	NCT01611766	Ovarian Epithel... Fallopian Tube ... Primary Periton...	Secondary Cytor... Salvage Chemoth...	18 Years - 80 Years	Shanghai Gynecologic Oncology Group
Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy	NCT04204811	Ovarian Cancer Stage III Ovari... Stage IV Ovaria... Primary Periton... Fallopian Tube ... Fallopian Tube ...	Prehabilitation	18 Years -	Memorial Sloan Kettering Cancer Center
Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer	NCT02125513	Ovarian Cancer Fallopian Tube ... Peritoneal Carc...	carboplatin and...	18 Years -	IRCCS Azienda Ospedaliero-Universitaria di Bologna
Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer	NCT03297489	Fallopian Tube ... Primary Periton... Stage I Ovarian... Stage IA Ovaria... Stage IB Ovaria... Stage IC Ovaria... Stage II Ovaria... Stage IIA Ovari... Stage IIB Ovari... Stage IIC Ovari... Stage III Ovari... Stage IIIA Ovar... Stage IIIB Ovar... Stage IIIC Ovar... Stage IV Ovaria...	Diagnostic Micr... Fluorescein Sod... Laboratory Biom...	18 Years -	Roswell Park Cancer Institute
Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives	NCT04257045	Breast Carcinom... Deleterious CDH... Deleterious DIC... Deleterious SMA... Deleterious STK... Endometrial Car... Fallopian Tube ... Ovarian Carcino... Primary Periton...	Interview Questionnaire A... Survey Administ...	18 Years -	M.D. Anderson Cancer Center
Oregovomab With or Without Cyclophosphamide in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Responded to Second-Line Chemotherapy	NCT00551265	Fallopian Tube ... Primary Periton... Recurrent Ovari... Stage III Ovari... Stage IV Ovaria...	Cyclophosphamid... Laboratory Biom... Oregovomab	18 Years -	GOG Foundation
Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer	NCT02118285	Ovarian Cancer Fallopian Tube ... Primary Periton...	Fludarabine Cyclophosphamid... NK cells IL-2 INCB024360	18 Years -	Masonic Cancer Center, University of Minnesota
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation	NCT05059444	Bladder Carcino... Ureter Carcinom... Renal Pelvis Ca... Non-small Cell ... Invasive Breast... Cutaneous Melan... Esophageal Carc... Gastroesophagea... Gastric Adenoca... Pancreatic Aden... Squamous Cell C... Epithelial Ovar... Fallopian Tube ... Endometrial Car... Renal Cell Carc...	Guardant Reveal	18 Years -	Guardant Health, Inc.
Photoacoustic Imaging in Detecting Ovarian or Fallopian Tube Cancer	NCT02530606	Fallopian Tube ... Ovarian Carcino...	Photoacoustic I...	18 Years - 80 Years	Stanford University
A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma	NCT00434642	Ovarian Cancer	Carboplatin Gemcitabine Bevacizumab Placebo	18 Years -	Genentech, Inc.
Symptom Management in Patients With Recurrent or Persistent Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	NCT00958698	Fallopian Tube ... Primary Periton... Psychological I... Recurrent Ovari...	Communication I... Educational Int... Internet-Based ... Psychosocial As... Quality-of-Life... Questionnaire A...	18 Years -	GOG Foundation
Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma	NCT01381861	Recurrent Ovari... Fallopian Tube ... Primary Periton...	Carotuximab (TR...	18 Years -	Tracon Pharmaceuticals Inc.
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites	NCT00326885	Malignant Ascit...	catumaxomab	18 Years -	Neovii Biotech
Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)	NCT02584478	Endometrial Car... Ovarian Carcino... Fallopian Tube ... Primary Periton... Cervical Carcin...	AL3818 Paclitaxel Pegylated Lipos... Topotecan Topotecan Carboplatin Paclitaxel AL3818	18 Years -	Advenchen Laboratories, LLC
A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	NCT00939809	Fallopian Tube ... Malignant Ovari... Ovarian Brenner... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Serous ... Primary Periton... Recurrent Ovari... Undifferentiate...	Urokinase-Deriv... Laboratory Biom...	18 Years -	GOG Foundation
Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	NCT01295489	Fallopian Tube ... Ovarian Carcino... Primary Periton...	Laboratory Biom...	18 Years -	GOG Foundation
Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer	NCT01202890	Ovarian Cancer Epithelial Ovar... Fallopian Tube ... Primary Periton...	Lenalidomide, L... Revlimid, Doxil...	-	New Mexico Cancer Care Alliance
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	NCT00499252	Fallopian Tube ... Primary Periton... Recurrent Ovari...	Paclitaxel Albu...	-	GOG Foundation
First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer	NCT01097746	Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... FIGO Stage III ... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIA... FIGO Stage IIIB... FIGO Stage IIIC... FIGO Stage IVA ... FIGO Stage IVB ... Malignant Ovari... Ovarian Clear C... Ovarian Endomet... Ovarian Mucinou... Ovarian Seromuc... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Primary Periton... Primary Periton...	Bevacizumab Carboplatin Paclitaxel	18 Years -	M.D. Anderson Cancer Center
Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer	NCT02125513	Ovarian Cancer Fallopian Tube ... Peritoneal Carc...	carboplatin and...	18 Years -	IRCCS Azienda Ospedaliero-Universitaria di Bologna
Safety and Efficacy Study of Catumaxomab to Treat Ovarian Cancer After a Complete Response to Chemotherapy	NCT00377429	Ovarian Cancer	catumaxomab	18 Years -	Neovii Biotech
Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer	NCT02788708	Fallopian Tube ... Recurrent Ovari... Primary Periton... Recurrent Endom...	Lenvatinib Mesy... Paclitaxel Pharmacological...	18 Years -	Ohio State University Comprehensive Cancer Center
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies	NCT02419495	Advanced Malign... Clinical Stage ... Clinical Stage ... Fallopian Tube ... Metastatic Lung... Metastatic Mali... Metastatic Mela... Metastatic Rena... Ovarian Carcino... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Pathologic Stag... Primary Periton... Stage III Lung ... Stage III Renal... Stage IIIA Lung... Stage IIIB Lung... Stage IIIC Lung... Stage IV Lung C... Stage IV Renal ... Stage IVA Lung ... Stage IVB Lung ... Triple-Negative... Unresectable Lu... Unresectable Me... Unresectable Re...	Capecitabine Carboplatin Cyclophosphamid... Doxorubicin Eribulin Fluorouracil Ipilimumab Irinotecan Hydr... Leucovorin Calc... Nivolumab Olaparib Oxaliplatin Paclitaxel Pembrolizumab Pemetrexed Selinexor Topotecan	18 Years -	M.D. Anderson Cancer Center
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation	NCT05059444	Bladder Carcino... Ureter Carcinom... Renal Pelvis Ca... Non-small Cell ... Invasive Breast... Cutaneous Melan... Esophageal Carc... Gastroesophagea... Gastric Adenoca... Pancreatic Aden... Squamous Cell C... Epithelial Ovar... Fallopian Tube ... Endometrial Car... Renal Cell Carc...	Guardant Reveal	18 Years -	Guardant Health, Inc.

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: